MOLOGIC IS HAVING A DRAMATIC IMPACT ON DIAGNOSIS & TREATMENT OF DISEASES.
Mologic innovations are having a continuing dramatic impact on the diagnosis and treatment of infections and infectious diseases.
Sepsis is a life-threatening illness. The single most expensive condition treated in hospitals, it is a leading cause of death in EDs and ICUs worldwide. A rapid diagnostic for sepsis does not yet exist.
Peritoneal dialysis is the preferred treatment for ESRD patients because it offers a better quality of life, but leaves patients prone to peritoneal infection. The diagnosis is limited to visual bag inspection and patient symptoms.
Dengue is at epidemic levels in more than 110 countries with incidence growing by 10% every year.
Periodontal Disease is strongly linked to bone loss in the jaw and to a higher incidence of heart disease. Early diagnosis relies on qualitative methods for periodontal disease, and is limited to radiographs for early detection of bone loss.
Diagnostic tests in development include:
SepsisDX
PERiPLEX
DengueDX
DENTiPLEX
DENTiPLEX BL
SepsisDX is a rapid test of whole blood for the early detection of sepsis. (Multiplex.)
PERiPLEX is a rapid test of dialysis effluent to detect peritoneal dialysis infection by testing for enzyme activity.
DengueDX is a finger stick rapid whole blood test for Dengue, enabling early detection by measuring IgG/IgM/NS-1.
DENTiPLEX is a rapid test of gingival crevicular fluid for host response biomarkers, indicating periodontal health and potential periodontitis and peri-implantitis.
DENTiPLEX BL checks for oral bone loss via a rapid test of gingival crevicular fluid, which detects host response biomarkers indicating bone loss or a degradation in bone density.